Cargando…
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL
SIMPLE SUMMARY: The overall survival rate in T-cell acute lymphoblastic leukemia (T-ALL) patients is relatively high. However, the therapeutic options for refractory and relapsed cases with poor prognosis are still limited. Therefore, novel therapies are required to improve high-risk patient outcome...
Autores principales: | Zhdanovskaya, Nadezda, Lazzari, Sara, Caprioglio, Diego, Firrincieli, Mariarosaria, Maioli, Chiara, Pace, Eleonora, Imperio, Daniela, Talora, Claudio, Bellavia, Diana, Checquolo, Saula, Mori, Mattia, Screpanti, Isabella, Minassi, Alberto, Palermo, Rocco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736653/ https://www.ncbi.nlm.nih.gov/pubmed/36497257 http://dx.doi.org/10.3390/cancers14235772 |
Ejemplares similares
-
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
por: Zhdanovskaya, Nadezda, et al.
Publicado: (2021) -
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL
por: Tottone, Luca, et al.
Publicado: (2019) -
PLK1 targets NOTCH1 during DNA damage and mitotic progression
por: De Blasio, Carlo, et al.
Publicado: (2019) -
Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells
por: Ceccarelli, Simona, et al.
Publicado: (2019) -
Wnt, Notch, and TGF-β Pathways Impinge on Hedgehog Signaling Complexity: An Open Window on Cancer
por: Pelullo, Maria, et al.
Publicado: (2019)